Global Intracranial Pressure Monitoring Devices Market Size To Exceed USD 3.46 Billion by 2033: Market Statistics Report

Global Intracranial Pressure Monitoring Devices Market Size To Exceed USD 3.46 Billion by 2033

According to a research report published by Spherical Insights & Consulting, The Global Intracranial Pressure Monitoring Devices Market Size is Expected to Grow from USD 1.69 Billion in 2023 to USD 3.46 Billion by 2033, at a CAGR of 7.43% during the forecast period 2023-2033.  

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Intracranial Pressure Monitoring Devices Market Size, Share, and COVID-19 Impact Analysis, By Technique (Invasive and Non-invasive), By Application (Traumatic Brain Injury and Intracerebral Hemorrhage), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

The global intracranial pressure monitoring devices market refers to the industry focused on developing and advertising medical equipment that measures pressure inside the skull for the purpose of aiding in the diagnosis and treatment of neurological disorders, brain traumas, and other significant illnesses affecting brain pressure. Key driving factors for the growth of the intracranial pressure monitoring devices market include increasing neurological conditions, aging populations, improvements in medical technology, and higher spending on healthcare. The increasing use of these tools for the efficient treatment of brain disorders is additionally facilitated by government programs and increased awareness among the public. However, concerns regarding device accuracy and dependability, a shortage of qualified personnel, and inadequate healthcare infrastructure in underdeveloped nations are the main obstacles limiting market expansion.

The invasive segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period.

On the basis of technique, the global intracranial pressure monitoring devices market is divided into invasive and non-invasive. Among these, the invasive segment accounted for the largest revenue share in 2023 and is projected to grow at a significant CAGR during the forecast period.  The segment growth is attributed to the deployment of intrusive ICP techniques is being fueled by the rising incidence of neurological illnesses, the requirement for accurate and continual surveillance in intensive care units, and developments in sensor technology for precise pressure measurement.

The traumatic brain injury segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

On the basis of application, the global intracranial pressure monitoring devices market is divided into traumatic brain injury and intracerebral hemorrhage. Among these, the traumatic brain injury segment accounted for the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segment growth is driven by increased rates of traumatic brain injuries, improvements in ICP monitoring tools, and products like the ReFlow EVD, which assists in treating high intracranial pressure.

North America is anticipated to hold the largest share of the global intracranial pressure monitoring devices market over the predicted timeframe.

North America is anticipated to hold the largest share of the global intracranial pressure monitoring devices market over the predicted timeframe. The regional market growth can be attributed to an increased need for non-invasive monitoring tools, enhanced healthcare, and a rise in traumatic brain injuries, strokes, and chronic illnesses, all of which are driving market expansion in the region.

Asia Pacific is expected to grow at the fastest CAGR in the global intracranial pressure monitoring devices market during the forecast period. The regional market growth is driven by significant market expansion, such as a large aging population, particularly in Japan, rising healthcare investments in countries like China and India, and a strong need for critical and post-traumatic treatment.

Company Profiling

Major vendors in the global intracranial pressure monitoring devices market are Medtronic, Integra LifeSciences, RAUMEDIC AG, Sophysa, Spiegelberg GmbH & Co. KG. (Luciole Medical AG), Natus Medical, Digitimer Ltd, NeuraSignal, Inc., and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In March 2025, Anuncia Inc. announced that it received Breakthrough Device Designation from the U.S. FDA for its ReFlow EVD, an innovation-driven solution for external ventricular drains to manage elevated intracranial pressure and brain swelling.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global intracranial pressure monitoring devices market based on the below-mentioned segments: 

Global Intracranial Pressure Monitoring Devices Market, By Technique

• Invasive
• Non-invasive

Global Intracranial Pressure Monitoring Devices Market, By Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage

Global Intracranial Pressure Monitoring Devices Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa